Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS -1.19%12 Operating Cash Flow per Share is $-1.52 as of Apr. 2026. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 6 warning signs investors should review. Among 650 Medical Devices & Instruments companies, Kestra Medical Technologies ranks better than 66.15% on this metric.
Kestra Medical Technologies's operating cash flow per share for the
three
months ended in Apr. 2026 was $-0.32.
Kestra Medical Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Apr. 2026 was $-1.52.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Kestra Medical Technologies's Operating Cash Flow per Share or its related term are showing as below:
KMTS'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -33.6 Med: -28.1 Max: 24.5
Current: 24.5
During the past 6 years, Kestra Medical Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 24.50% per year. The lowest was -33.60% per year. And the median was -28.10% per year.
KMTS's 3-Year OCF Growth Rate is ranked better than 66.15% of 650
companies
in the Medical Devices & Instruments industry
Industry Median: 12.4
vs KMTS: 24.50
Kestra Medical Technologies Operating Cash Flow per Share Related Terms
Kestra Medical Technologies Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Kestra Medical Technologies's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kestra Medical Technologies Operating Cash Flow per Share Chart
KMTS vs AZTA, STAA, BLFS: Operating Cash Flow per Share Comparison
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $-1.52 mean?
Kestra Medical Technologies (KMTS) has a Operating Cash Flow per Share of $-1.52 as of Apr. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Kestra Medical Technologies and its competitors. According to the industry distribution chart, Kestra Medical Technologies ranks #220 out of 650 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Kestra Medical Technologies' Operating Cash Flow per Share too high?
Kestra Medical Technologies' current Operating Cash Flow per Share is $-1.52. Based on the distribution chart, Kestra Medical Technologies ranks #220 out of 650 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Operating Cash Flow per Share compare to AZTA and STAA?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #220 out of 650 companies for Operating Cash Flow per Share. This puts Kestra Medical Technologies in the upper half of its industry. The industry median Operating Cash Flow per Share is 12.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.40, based on 650 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Kestra Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current Operating Cash Flow per Share is $-1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Operating Cash Flow per Share of $-1.52. The current Operating Cash Flow per Share is $-1.52. Kestra Medical Technologies' overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Operating Cash Flow per Share is $-1.52 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score
Get the complete analysis for KMTS
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
